Literature DB >> 1348818

C1-inhibitor concentrate for sepsis-related capillary leak syndrome.

W Nürnberger, U Göbel, H Stannigel, B Eisele, A Janssen, U Delvos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1348818     DOI： 10.1016/0140-6736(92)91564-o

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Intensive care.

Authors:  S Sinclair; M Singer
Journal:  Postgrad Med J       Date:  1993-05       Impact factor: 2.401

Review 2.  C1 inhibitor: molecular and clinical aspects.

Authors:  Marco Cicardi; Lorenza Zingale; Andrea Zanichelli; Emanuela Pappalardo; Benedetta Cicardi
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

3.  Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis.

Authors:  Sacha Zeerleder; Christoph Caliezi; Gerard van Mierlo; Anke Eerenberg-Belmer; Irmela Sulzer; C Erik Hack; Walter A Wuillemin
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

Review 4.  Perspectives for the future.

Authors:  E F Mammen
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

5.  C1 esterase inhibitor (C1-INH) can reduce plasma concentrations of the complement activation product C5a.

Authors:  W Nürnberger; K Petrik; S Burdach; U Göbel
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 6.  Genome-wide and Phenome-wide Approaches to Understand Variable Drug Actions in Electronic Health Records.

Authors:  Jamie R Robinson; Joshua C Denny; Dan M Roden; Sara L Van Driest
Journal:  Clin Transl Sci       Date:  2017-11-17       Impact factor: 4.689
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.